ERF — Eurofins Scientific SE Balance Sheet
0.000.00%
- €10.06bn
- €13.10bn
- €6.95bn
- 96
- 40
- 95
- 93
Annual balance sheet for Eurofins Scientific SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 912 | 515 | 487 | 1,221 | 614 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,389 | 1,581 | 1,597 | 1,617 | 1,609 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,518 | 2,319 | 2,313 | 3,066 | 2,452 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,575 | 1,830 | 2,168 | 2,297 | 2,560 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 8,576 | 9,332 | 10,084 | 10,889 | 10,888 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,696 | 1,856 | 1,772 | 2,122 | 2,110 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 4,885 | 4,685 | 5,301 | 5,811 | 5,550 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 3,690 | 4,648 | 4,782 | 5,078 | 5,339 |
Total Liabilities & Shareholders' Equity | 8,576 | 9,332 | 10,084 | 10,889 | 10,888 |
Total Common Shares Outstanding |